The FDA has requested the labeling for all desmopressin products be updated to include new information about severe hyponatremia and seizures.

The FDA has approved Triesence 40mg/mL (triamcinolone acetonide injectable suspension, from Alcon), a preservative-free synthetic corticosteroid for use in eye surgery and treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

The FDA has approved the use of Diovan (valsartan, from Novartis) for the treatment of high blood pressure in children and adolescents 6-16 years of age.